Clinical Features and Outcomes of Treatment for Effusive Feline Infectious Peritonitis with GS-441524 in Seventeen Retrovirus-Positive Cats
Treatment success for retrovirus-positive cats with presumptive FIP was similar to previously reported outcomes for FIP alone. This could support current evidence of successful antiviral therapy for similar populations, if noncurrent, unstandardized protocols and unlicensed product use are considered. Additional studies are needed to determine ideal protocols for rapid resolution of FIP, good long-term survival, and limited relapse in retrovirus-positive cats, and the impact of the FeLV proviral load.
Authors
- Rosa Negash (ORCID: https://orcid.org/0009-0009-3181-2638)
- Nicole Jacque
- Emma C. Hart (ORCID: https://orcid.org/0000-0002-4534-9586)
- Wendy M. Novicoff (ORCID: https://orcid.org/0000-0002-5146-7706)
- JK Levy
- Sarah E. Jones (ORCID: https://orcid.org/0000-0002-6036-0679)
- Marilize Van der Walt
- Samantha J. M. Evans
Institutions
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- University of Florida (US)
- Friends United (US)
- Ohio University (US)
- Film Independent (US)
- University of Virginia (US)
- Colorado State University (US)
Publication Details
- Journal
- Pathogens
- Published
- 2026-03-21
- DOI
- https://doi.org/10.3390/pathogens15030337
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00